MyChesCo on MSN19h
Traws Pharma Announces Virtual Investor Event to Showcase Innovative Treatments for Bird Flu and COVID-19NEWTON, PA — Traws Pharma, Inc. (NASDAQ: TRAW) is set to host a virtual investor event on Monday, March 31, 2025, at 10:00 AM ...
Cell-free systems, which can express an easily detectable protein with a DNA or mRNA template without constraints of living ...
Dewpoint will present two posters at AACRCondensate modulators (c-mods) demonstrate robust anti-tumor effects across multiple ...
Multiple presentations demonstrate that T-knife’s proprietary next-generation technologies address important challenges with current cell therapy ...
About NRX-0305 NRX-0305 is a potent, selective, and orally bioavailable mutant-specific BRAF degrader that Nurix is exploring for use in oncology. Nurix has reported preclinical data demonstrating ...
In a groundbreaking study on the synthesis of cellulose—a major constituent of all plant cell walls—a team of Rutgers University-New Brunswick researchers have captured images of the microscopic ...
Cameron University biology students presented their research findings and won awards at the Texas Society of Mammalogists's annual conference.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback